1 / 58

Environmental Toxicology

Environmental Toxicology. Toxicants in Living Organisms. Ingestion  Excretion. Phys/chem properties impt Forms Gases, vapors (evap’d solvents), dusts Liquids (in H 2 O) Solids (dissolved). Ingestion  Excretion. Phys/chem properties – cont’d pH, pKa, solubility

masseyp
Télécharger la présentation

Environmental Toxicology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Environmental Toxicology Toxicants in Living Organisms

  2. Ingestion  Excretion • Phys/chem properties impt • Forms • Gases, vapors (evap’d solvents), dusts • Liquids (in H2O) • Solids (dissolved)

  3. Ingestion  Excretion • Phys/chem properties – cont’d • pH, pKa, solubility • Absorption effected? (ex: pH) • Effects toxicity • Ex: aspirin acidic, but neutral in stomach • Must be soluble in body/cell fluids for abs’n • Lipid solubility also impt • Cell membr mostly lipid

  4. Thiopental Secobarbital

  5. Introduction of Toxicants • Exposure • Concentration, dose • Duration, frequency • Site, route • Figure 5.2 • Variations • Species/strain differences • Genetic/health status • Environmental factors (light, temp, etc.)

  6. Sites of Ingestion • Skin • Mostly liquids, solutes in sol’n, suspensions • Greatest area: epidermal cells •  blood, lymph  body • Blood flow impt • Penetration depends on • Phys/chem properties of toxicant • Skin penetrability • In gen’l nonpolar agents enter

  7. Sites of Ingestion – cont’d • Lungs • Inhale gases, very fine solids/liquids • Major function – gas exch between blood/air

  8. Lungs – cont’d • Alveoli • Thin tissue • Susceptible to absorption gases other than O2 • Toxicants directly  blood • Rel large concentrations • Itself susceptible • Particles retained on cilia  irritation

  9. Sites of Ingestion-- cont’d • Gastrointestinal (GI) • Major route for solids • Tube: mouth  anus • Open to environment • Designed to metabolize, absorb nutrients • Stomach • Low pH promotes abs’n some compounds

  10. GI – cont’d • Small intestine • Absorption • Enterohepatic circulation • Intestine  blood  liver  bile  gi  blood • Liver • “Screening organ”

  11. Toxicant Storage • Fat • Lipophilic compounds • Many pesticides • Bone • Compounds that bind CaPO4 • Includes small ions

  12. In Cells: Sites of Toxicity • Nucleus • Contains chromosomes (DNA + proteins) • Genes code for partic proteins • DNA dbl helix w/ precise structure, bonds, etc • Proper base pairing • H bonds between bases

  13. Nucleus – cont’d • Transcription • Many steps, proteins nec • DNA  mRNA • Translation • Many steps, proteins nec • mRNA  protein

  14. Nucleus – cont’d • Toxicants may • Physically disrupt DNA helix • Disrupt repl’n process • Decr’d # new cells • Chem’ly alter bases • Improper base pairing • Mutations • ~ 500 diseases w/ 1 aa change • Often due to defect in genetic code

  15. Major Sites of Toxicants in Cells – cont’d • Enzymes • Proteins that catalyze cellular rxns • Proteins have partic structures • Based on aa’s that make them up • Can be disrupted by cell phys/chem changes

  16. Enzymes – cont’d • Active site • Region holds substrate(s) by multiple weak chem. interactions • Atoms of aa side chains participate in rxn w/ substrate(s) • Rxn catalyzed by lowering energy nec for rxn to take place • Common mech of toxicants is destruction of enz’s, or disruption of their catalytic ability

  17. http://www.blobs.org/science/enzyme/imgs/active2.gif

  18. Enzymes – cont’d • Toxicants may: • Bind covalently at enz active site or other site on enzyme • Compete for enz active site • Unravel enz folding

  19. Enzymes (cont’d) • Toxicants may (cont’d): • Inactivate impt cofactor (inorganic ion nec for enz activity) • Form complex w/ cofactor • Book ex: enolase catalyzes 2-phosphoglycerate  phosphoenolpyruvate; req’s Mg+2 • Presence of F  Mg-F-PO4 complex  inact’n enz • Compete with cofactor • Book ex: Cd replaces Zn

  20. Major Sites of Toxicants in Cells – cont’d • Metabolic Processes • Mitochondria impt • Respiration – aerobic (O2) • Also, anaerobic • Anabolism/catabolism

  21. Metabolic Processes – cont’d • Redox reactions • Shift electrons (1 mol loses e- as [H-] or [H+ + e-]; another gains) • Impt to ATP synth (cell energy) • Toxicants may • Alter enz’s impt to metab  improper metabolite • Use metabolic enz’s for toxicant metab  improper metabolite

  22. Major Sites of Toxicants in Cells – cont’d • Cell Membrane • Encloses cell • Mostly lipid • Receptor proteins • Lipophilic substances enter • Specific • Cell biochem rxns depend on these

  23. Cell Membrane – cont’d • Toxicants may • Damage lipid bilayer • Damage receptors or shift their structures • Oxidize lipids • Smooth Endoplasmic Reticulum • Contains enzymes involved in metabolism of toxicants

  24. Toxicant Metabolism • Chem nature of toxicants • Extremes of acidity/basicity/ability to add or remove H2O • Corrosive, caustic compounds • Irritants • Very reactive toward mol’s in tissues

  25. Chem nature of toxicants (cont’d) • Highly reactive substances • Bonds, functional groups easily react w/ biomolecules  damage • Ex: allyl alcohol vs propanol • Ex: peroxides • Heavy metals • Many react w/ proteins (so enzymes) • May bind –SH grp (cysteine) OH

  26. Chem nature of toxicants (cont’d) • Compounds that bind impt proteins • Reversibly or irreversibly • Ex: CO irreversibly binds Hb • Lipid-soluble compounds • Traverse lipid bilayer • Enter cells easily

  27. Metabolism – cont’d • Ingested toxicant may be • Abs’d as parent • Metab’d first, then abs’d • Stored • Excreted • In general, acted on by metabolic enz’s • Mistaken for food • “Biotransformation” • BUT nonenzymatic biotransformations also • Figure 10.2 – good summary

  28. Dependent on phys/chem properties of xenobiotic • Highly polarized/ionized • Don’t enter cells • Rapidly excr’d • Little harm • Volatile • Expelled quickly from lungs • Little harm • Nonpolar (lipophilic) • Less soluble in aqueous body fluids • Attracted to body lipids • Can accumulate in tissues, fat

  29. Sites of Biotransformation • Metabolic enz’s in tissues • Mostly sites of xenobiotic entry • Skin, lung, gut wall • Incr’d levels metab enz’s • Liver significant • Many types of metabolizing enzymes • “Screening organ” • Sees xenobiotics from g.i. • Enterohepatic circulation • Cycles compounds back to liver

  30. Toxification/Detoxification • Metab  detox’d xenobiotic  more easily excr’d • Metab  tox’d xenobiotic  more harmful to cells, body • Ex: polycyclic aromatic hydroxcarbons epoxidized  reactive cmpd

  31. Phase I Rxns • Introduce reactive, polar functional grps onto lipophilic mol’s • Modify funct’l grps  more hydrophilic •  Xenobiotic that looks much diff than parent •  Product more easily excr’d OR •  Product w/ correct chem. structure to undergo Phase II metab

  32. If not metab’d, lipophilic xenobiotics enter cells or bind serum prot’s & dist’d • Product of Phase I rxns = metabolite more water soluble than parent • More easily excr’d • BUT may be more reactive to cell molecules

  33. Redox Review • Reduction/oxidation rxns • Oxidation = loss electrons • Addition O to structure • Ex: epoxidation • Loss H- (H:) • So ox’d cmpds have fewer H’s or more O’s

  34. Reduction = gain electron • Common: gain H- • So red’d cmpds have more H’s • Ex: coenzymes (NAD+  NADH)

  35. Metabolic Oxidations • Type of Phase I rxn • Frequently by enz’s introducing O • From O2 in body • Mixed Function Oxidases (mfo’s) • Substr + O2 Prod-OH + H2O • Ex: Cytochromes P450

  36. Impt for endogenous mol’s or nutrients • “Microsomal” • Contained in membr’s of organelles • Sep’d by centrifugation

  37. Key enz’s = Cytochromes P450 • Contain heme + Fe + reductase assoc’d • Flavin, NAD coenzymes • Bind O2, add/receive electrons • Liver highest concent in mammals • BUT also other tissues • Table 3.1 • Not all oxidations are microsomal • Ex: Dehydrogenases oxidize –OH • Fig. 10.3

  38. Metabolic Oxidation Rxns of Carbon • Add –OH grps to C’s of HC’s • Add –O- between 2 C’s w/ multiple bond • If unstable get rearrangement • Epoxide form’n  more toxic metabolite • Electron rich • Strained ring structure

  39. Metabolic Oxidation Rxns of Noncarbon Elements • N, O, S • Add’n O to N,S • Dehydrohalogenation (nonmicrosomal) • H cleavage near O • Add O

  40. Metabolic Reductions • Gen’ly by reductase enz’s • Liver, kidney, lung, others • Intestinal flora enz’s work on S • Reductive dehalogenation

  41. Hydrolysis (not a redox rxn) • Add H2O across C-C bond  2 prod’s • Ex: epoxide hydratase • Esters, amides • Impt functional grps hydrolyzed • Found in many pesticides • Esterases, amidases • Found in liver • May detoxify or increase toxicity

  42. http://www.blobs.org/science/metabolism/atp/hydrolysis/option2.gifhttp://www.blobs.org/science/metabolism/atp/hydrolysis/option2.gif

  43. Phase II Reactions • Conjugating • Xenobiotic or metabolite of xenobiotic bound to endogenous cmpd • Endogenous cmpd chem’ly activated yields energy for rxn • Xenobiotic funct’l grp = “chemical handle” to which endogenous cmpd is bound

  44. Phase II Reactions • Increases excr’n • Funct’l grp may have been formed by Phase I rxn • Prod more aqueous soluble • Prod less lipid soluble • Prod gen’ly less toxic

  45. Phase II Reactions • Glucuronides • Conjugated w/ uridine diphosphate glucuronic acid (UDPGA) • Glucuronyl transferase • Prod’s classified by funct’l grp element to which glucuronide bound

More Related